Suppr超能文献

体外分析青蒿提取物对恶性疟原虫的作用表明其具有复杂的抗疟效果。

In vitro analyses of Artemisia extracts on Plasmodium falciparum suggest a complex antimalarial effect.

机构信息

Department of Biology and Biotechnology, Worcester Polytechnic Institute, Worcester, Massachusetts, United States of America.

出版信息

PLoS One. 2021 Mar 2;16(3):e0240874. doi: 10.1371/journal.pone.0240874. eCollection 2021.

Abstract

Dried-leaf Artemisia annua L. (DLA) antimalarial therapy was shown effective in prior animal and human studies, but little is known about its mechanism of action. Here IC50s and ring-stage assays (RSAs) were used to compare extracts of A. annua (DLAe) to artemisinin (ART) and its derivatives in their ability to inhibit and kill Plasmodium falciparum strains 3D7, MRA1252, MRA1240, Cam3.11 and Cam3.11rev in vitro. Strains were sorbitol and Percoll synchronized to enrich for ring-stage parasites that were treated with hot water, methanol and dichloromethane extracts of DLA, artemisinin, CoArtem™, and dihydroartemisinin. Extracts of A. afra SEN were also tested. There was a correlation between ART concentration and inhibition of parasite growth. Although at 6 hr drug incubation, the RSAs for Cam3.11rev showed DLA and ART were less effective than high dose CoArtem™, 8 and 24 hr incubations yielded equivalent antiparasitic results. For Cam3.11, drug incubation time had no effect. DLAe was more effective on resistant MRA-1240 than on the sensitive MRA-1252 strain. Because results were not as robust as observed in animal and human studies, a host interaction was suspected, so sera collected from adult and pediatric Kenyan malaria patients was used in RSA inhibition experiments and compared to sera from adults naïve to the disease. The sera from both age groups of malaria patients inhibited parasite growth ≥ 70% after treatment with DLAe and compared to malaria naïve subjects suggesting some host interaction with DLA. The discrepancy between these data and in-vivo reports suggested that DLA's effects require an interaction with the host to unlock their potential as an antimalarial therapy. Although we showed there are serum-based host effects that can kill up to 95% of parasites in vitro, it remains unclear how or if they play a role in vivo. These results further our understanding of how DLAe works against the malaria parasite in vitro.

摘要

干叶青蒿素 L.(DLA)抗疟疗法在先前的动物和人体研究中显示有效,但对其作用机制知之甚少。在这里,使用 IC50 和环状阶段测定(RSA)来比较青蒿素(ART)及其衍生物的提取物与青蒿素(ART)及其衍生物在抑制和杀死体外 3D7、MRA1252、MRA1240、Cam3.11 和 Cam3.11rev 疟原虫株方面的能力。用山梨醇和 Percoll 同步化处理,富集富含环阶段寄生虫,并用 DLA、青蒿素、CoArtem™和二氢青蒿素的热水、甲醇和二氯甲烷提取物处理寄生虫。还测试了 A. afra SEN 的提取物。ART 浓度与寄生虫生长抑制之间存在相关性。尽管在 6 小时药物孵育时,Cam3.11rev 的 RSA 显示 DLA 和 ART 的效果不如高剂量 CoArtem™,但 8 和 24 小时孵育则产生等效的抗寄生虫效果。对于 Cam3.11,药物孵育时间没有影响。DLAe 对耐药 MRA-1240 的效果优于敏感 MRA-1252 株。由于结果不如动物和人体研究中观察到的那样稳健,因此怀疑存在宿主相互作用,因此使用从肯尼亚疟疾成年和儿科患者采集的血清进行 RSA 抑制实验,并与对疾病无免疫力的成年人的血清进行比较。来自疟疾患者的两组年龄的血清在用 DLAe 处理后抑制寄生虫生长≥70%,与疟疾无免疫力的患者相比表明与 DLA 存在一些宿主相互作用。这些数据与体内报告之间的差异表明,DLA 的作用需要与宿主相互作用才能释放其作为抗疟疗法的潜力。尽管我们表明存在基于血清的宿主效应,可在体外杀死高达 95%的寄生虫,但仍不清楚它们如何或是否在体内发挥作用。这些结果进一步加深了我们对 DLAe 体外抗疟原虫作用的理解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/974c/7924776/928fe8582eb2/pone.0240874.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验